J&J's coronavirus vaccine faces new US limits
Bio Pharma Dive
DECEMBER 16, 2021
Days after the FDA strengthened safety warnings for the company's shot, a CDC panel recommended Pfizer's and Moderna's vaccines be "preferred" over J&J's.
Bio Pharma Dive
DECEMBER 16, 2021
Days after the FDA strengthened safety warnings for the company's shot, a CDC panel recommended Pfizer's and Moderna's vaccines be "preferred" over J&J's.
Pharma Mirror
DECEMBER 16, 2021
Impaired driving due to prescription medication is often given less attention than driving under the influence of illegal drugs. Yet, prescription drugs are just as dangerous, if not more dangerous, because many people are either not aware of the drug’s influence on their driving or assume prescribed medication is “safe.” Some medication, however, significantly increases the risk of car crashes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
DECEMBER 16, 2021
Novartis is using funds gained from the recent sale of its stake in Roche to buy back $15 billion worth of its own shares, while Pfizer is signaling more dealmaking could follow its buyout of Arena.
NY Times
DECEMBER 16, 2021
The ruling said the company’s owners, members of the Sackler family, could not receive protection from civil lawsuits in return for a $4.5 billion contribution.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
DECEMBER 16, 2021
The European Medicines Agency is still reviewing Paxlovid but, citing fast increasing cases and deaths from COVID-19, offered flexibility to EU countries which may authorize emergency use.
Pharma Times
DECEMBER 16, 2021
Venetoclax is an oral once-daily treatment, which blocks the action of the B-cell lymphoma-2 protein, the presence of which helps cancer cells survive.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Drug Patent Watch
DECEMBER 16, 2021
Annual Drug Patent Expirations for XERAVA Xerava is a drug marketed by Tetraphase Pharms and is included in one NDA. There are two patents protecting this drug. This drug has…. The post New patent for Tetraphase Pharms drug XERAVA appeared first on DrugPatentWatch - Make Better Decisions.
Bio Pharma Dive
DECEMBER 16, 2021
In granting approval, the FDA gave Biogen roughly nine years to run and submit results from an additional study of Aduhelm. Now, the company says it will do so in about half the time.
NY Times
DECEMBER 16, 2021
The decision will broaden access to medication abortion, an increasingly common method, but many conservative states are already mobilizing against it.
Scienmag
DECEMBER 16, 2021
With over a million known species, insects are by far the most diverse group of organisms on Earth, with conservative estimates indicating there are millions more waiting to be found. But extinction due to human pressures may be outpacing the rate of discovery, with species disappearing before researchers even knew they existed. Credit: Florida Museum […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
XTalks
DECEMBER 16, 2021
Alternative meat brand Jack & Annie’s, which makes plant-based meat products from jackfruit, recently secured $23 million in a Series B funding round. Co-led by Creadev and Desert Bloom and existing investors Beta Angels and InvestEco, the funding round was the largest to date for the brand. So, how did Jack & Annie’s earn millions from investors and what will it do with the funding?
Scienmag
DECEMBER 16, 2021
Researchers at UT Southwestern Medical Center studied outcomes for young women at a county hospital and found that while 97% of them accessed prenatal care, those with greater social needs were associated with adverse outcomes both during pregnancy and during the early weeks of their babies’ lives. The differences persisted even after adjusting for age, race, […].
Pharma Times
DECEMBER 16, 2021
A warning has been issued to UK MPs from the head of NHS England that hospitalisations could exceed numbers recorded in January 2021.
Scienmag
DECEMBER 16, 2021
Researchers at QuTech—a collaboration between the TU Delft and TNO—have reached a milestone in quantum error correction. They have integrated high-fidelity operations on encoded quantum data with a scalable scheme for repeated data stabilization. The researchers report their findings in the December issue of Nature Physics. Credit: DiCarlo Lab and Marieke de Lorijn Researchers at […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Drug Channels
DECEMBER 16, 2021
This week, I’m rerunning some popular posts while I prepare for tomorrow's live video webinar: Drug Channels Outlook 2022. Hope you can join me! Click here to see the original post and comments from September 2021. Cardinal Health recently released the annual report for its 2021 fiscal year, which ended on June 30. See the links below. Today, I delve into the financials behind Cardinal’s relationship with its largest customer, CVS Health.
Scienmag
DECEMBER 16, 2021
In habituation, an organism gets so used to a ubiquitous sight, smell, sensation or sound that it virtually disappears. Runa Hamid of the CSIR-Centre for Cellular and Molecular Biology in Hyderabad, India, and colleagues have identified a transporter protein in the brain that plays a vital role in habituation, which they report in a new […].
pharmaphorum
DECEMBER 16, 2021
UK digital health company Brainomix has raised £16 million ($21.5 million) that will be used to extend the use of its artificial intelligence-based medical imaging software for stroke to new therapeutic areas. The Oxford University spinout – which has said that AI and machine learning is set to become the “driving force” behind imaging diagnostics – has its eye on diagnosing of lung fibrosis and cancer as it looks to expand its focus.
Scienmag
DECEMBER 16, 2021
The percentage of infants fully breastfed at 1,3, and 6 months significantly decreased during the COVID-19 pandemic among participants of the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) in Southern California. The percentage of infants who received any breastfeeding also decreased during these time periods, as reported in a study published in […].
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Outsourcing Pharma
DECEMBER 16, 2021
Professionals from various corners of the life-sciences field share views on significant challenges of 2021, bright spots, and what to look for in 2022.
Scienmag
DECEMBER 16, 2021
Often autistic adults can have several co-occurring physical and mental health conditions and, like in non-autistic adults, these may differ by racial and/or ethnic group. Researchers from Drexel University’s A.J. Drexel Autism Institute recently published research showing autistic adults on Medicaid have increased odds of some health, nutrition and psychiatric conditions, compared to the general […].
Outsourcing Pharma
DECEMBER 16, 2021
A leader from the information technology specialist explains how evolved thinking and digital transformation are leading to benefits across the industry.
Scienmag
DECEMBER 16, 2021
“Our simulations based on surveys and many other data reveal that mobility transition will be possible when attractive alternatives to the private car are provided and stricter regulations for motorized individual transport will be adopted,” says Dr. Martin Kagerbauer from KIT’s Institute for Transport Studies (IfV). “Our study provides major indications as to which elements […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Outsourcing Pharma
DECEMBER 16, 2021
While the pandemic saw many trials to shift to decentralized midstream, an expert from the trial tech firm suggests a ground-up design approach is preferable.
Scienmag
DECEMBER 16, 2021
Researchers recently made a major discovery – 14 new species of shrews, which is the largest number of new mammals described in a scientific paper since 1931. After a decade-long journey taking inventory of Indonesian shrews living on the island of Sulawesi, a group of scientists led by Louisiana State University mammologist Jake Esselstyn has […].
BioPharma Reporter
DECEMBER 16, 2021
Australia company, Inventia Life Science, which is focused on advanced 3D cell cultures for research and clinical purposes, has just closed a US$25M Series B funding round, led by Blackbird Ventures.
Scienmag
DECEMBER 16, 2021
MADISON — Small, unique antibody-like proteins known as VNARs — derived from the immune systems of sharks — can prevent the virus that causes COVID-19, its variants, and related coronaviruses from infecting human cells, according to a new study published Dec. 16. Credit: Bryce Richter / University of Wisconsin–Madison MADISON — Small, unique antibody-like proteins […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
NY Times
DECEMBER 16, 2021
On Thursday morning, prosecutors are expected to begin their closing arguments as they try to prove that Ms. Holmes, 37, is guilty of 11 counts of wire fraud and conspiracy to commit wire fraud.
Scienmag
DECEMBER 16, 2021
The unique beat of each person’s timed ticker has been pronounced just as identifiable as a fingerprint by some biotech companies. And while each heart may beat to a different rhythm, this rhythm should remain steady — patterned and predictable. The consistent pulsing and pumping of the heart provides oxygen-rich blood to the entire body […].
Outsourcing Pharma
DECEMBER 16, 2021
A leader from the R&D tech provider discusses the obstacles faced by drug development professionals in recent months, and ways they rose to the occasion.
Scienmag
DECEMBER 16, 2021
EMBARGOED UNTIL 2 P.M. ET (11 a.m. PT) ON THURSDAY, DECEMBER 16, 2021 Credit: Junqiao Wu, Lawrence Berkeley National Laboratory EMBARGOED UNTIL 2 P.M. ET (11 a.m. PT) ON THURSDAY, DECEMBER 16, 2021 Scientists have developed an all-season smart-roof coating that keeps homes warm during the winter and cool during the summer – without consuming […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Let's personalize your content